ListarInvestigación y Desarrollo por tema "antagonists and inhibitors"
Mostrando ítems 1-15 de 15
-
Article
-
Article
-
Article
Coumarin derivatives as promising xanthine oxidase inhibitors (2020)
(Elsevier B.V., 2018) -
Article
Deleterious effects of VEGFR2 and RET inhibition in a preclinical model of Parkinson’s disease (2020)
(Humana Press Inc., 2018) -
Article
-
Article
DT-Diaphorase Prevents Aminochrome-Induced Lysosome Dysfunction in SH-SY5Y Cells (2020)
(Springer New York LLC, 2019) -
Article
Environmental enrichment reverses tyrosine kinase inhibitor-mediated impairment through BDNF-TrkB pathway (2020)
(Humana Press Inc., 2018) -
Article
-
Review
HCN Channels: New therapeutic targets for pain treatment (2020)
(MDPI AG, 2018) -
Article
-
Article
Risk factors for tuberculosis in inflammatory bowel disease: Anti-tumor necrosis factor and hospitalization (2020)
(ARAN Ediciones S.A., 2016) -
Article
Side Fenestrations Provide an "anchor" for a Stable Binding of A1899 to the Pore of TASK-1 Potassium Channels (2020)
(American Chemical Society, 2017) -
Article
-
Article
Targeting α -(1,4)-glucosidase in diabetes mellitus type 2: The role of new synthetic coumarins as potent inhibitors (2020)
(Bentham Science Publishers B.V., 2018) -
Review
Urotensin II: Molecular mechanisms of biological activity (2020)
(Bentham Science Publishers B.V., 2018)